Caris Life Sciences (CAI) Research & Development (2024 - 2026)

Caris Life Sciences' Research & Development history runs 3 years deep, the most recent figure standing at $45.0 million for Q1 2026.

• In Q1 2026, Research & Development rose 13.09% year-over-year to $45.0 million; the TTM figure through Mar 2026 stood at $140.8 million (down 22.26% YoY), while the FY2025 annual figure was $101.6 million, down 33.43% from the prior year.
• Research & Development for Q1 2026 stood at $45.0 million, up from $31.8 million in the prior quarter.
• The five-year high for Research & Development was $65.8 million in Q4 2024, with the low at $21.6 million in Q3 2025.
• The 3-year median for Research & Development is $39.3 million (2024), against an average of $40.2 million.
• The sharpest annual moves came in 2025 and 2026: Research & Development slumped 51.6% in 2025, then climbed 13.09% in 2026.
• Caris Life Sciences' Research & Development stood at $65.8 million in 2024, then plunged by 51.6% to $31.8 million in 2025, then surged by 41.44% to $45.0 million in 2026.
• Business Quant data shows CAI's Research & Development at $45.0 million in Q1 2026, $31.8 million in Q4 2025, and $21.6 million in Q3 2025.